
Archiv der Pharmazie p. 239 - 244 (1996)
Update date:2022-08-17
Topics:
Schirmeister, Tanja
Aziridine-2,3-dicarboxylates and N-acylated derivatives have been evaluated as potential irreversible inhibitors of the cysteine proteinase papain. Dependence of inhibition activity on stereochemistry of the aziridine moiety has been analyzed. Whereas unsubstituted (R,R)- and (S,S)-diethyl aziridine-2,3-dicarboxylates (5) and (2) show no significant difference in inactivation the derivative acylated with BOC-(S)-Phe (BOC-(S)-Phe-(S,S)-Azi) (10) shows a 6 fold higher activity than the diastereomer BOC-(S)-Phe-(R,R)-Azi (11). Analogs acylated with Z- or BOC-(S)-Ala (9, 8) have lower second-order rate constants, indicating binding of the amino acid moiety of the inhibitors to the S2 subsite of the enzyme.
View More
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD
Contact:+86-571-88932183
Address:Hangzhou
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Doi:10.1039/a900441f
(1999)Doi:10.1007/s10534-018-0106-6
(2018)Doi:10.1039/jr9310001546
(1931)Doi:10.1016/j.tetlet.2005.10.010
(2005)Doi:10.1007/s10973-017-6956-2
(2018)Doi:10.1039/c3cy00323j
(2013)